News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mauna Kea Technologies, Inc. (Formerly known as Cellvizio Inc.) Partners With The Imperial College London To Advance Research And Applications Of Optical Biopsy With Cellvizio



12/12/2013 10:49:16 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Mauna Kea Technologies (Paris:MKEA) (NYSE Euronext: MKEA, FR0010609263) announced today it has entered into a research collaboration agreement with the Imperial College London, United-Kingdom, to develop next generation computer vision features for the use of optical biopsy based on the Cellvizio technology platform. The goal of this initiative will be to develop new imaging capabilities to improve the optical biopsy procedure and make it completely intuitive to clinicians of all specialties. This work will be done in coordination with Prof. Guang-Zhong Yang, Director of The Hamlyn Centre at Imperial College London.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES